Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Galecto Biotech
Galecto Biotech
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward
Xconomy
Sun, 09/27/20 - 11:07 pm
Galecto Biotech
idiopathic pulmonary fibrosis
IPF
GB0139
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto
Xconomy
Tue, 01/7/20 - 10:53 am
Amira Pharmaceuticals
Bristol-Myers Squibb
Celgene
PharmAkea
Galecto Biotech
fibrotic disease
Galecto Biotech Books $89 Million in Series C Financing to Develop Fibrosis Candidate
CP Wire
Fri, 10/26/18 - 09:50 am
Galecto Biotech
TD139
idiopathic pulmonary fibrosis
Galecto Biotech Books $89 Million in Series C Financing to Develop Fibrosis Candidate
Fri, 10/26/18 - 09:49 am
Galecto Biotech
TD139
idiopathic pulmonary fibrosis
Bristol-Myers beefs up fibrosis pipeline with $444M option deal
Fierce Biotech
Mon, 11/3/14 - 09:28 am
Bristol-Myers Squibb
Galecto Biotech
Denmark
M&A
IPF
idiopathic pulmonary fibrosis